Adam Houghton
Director/Board Member at Kojin Therapeutics, Inc.
Profile
Currently, Adam Houghton is Vice President for AbbVie Ventures.
Lord Houghton is also on the board of Kojin Therapeutics, Inc.
He previously was Senior Research Scientist at Procter & Gamble Co. and Senior Director & Head-Search & Evaluation at Biogen Corp.
Ltd.
Adam Houghton received an MBA from Xavier University and an undergraduate degree from Yale University.
Adam Houghton active positions
| Companies | Position | Start |
|---|---|---|
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Director/Board Member | - |
Former positions of Adam Houghton
| Companies | Position | End |
|---|---|---|
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 2021-08-31 |
| Biogen Corp. Ltd. | Director-Back Office Operation | 2018-02-27 |
| ELI LILLY AND COMPANY | Director/Board Member | 2015-02-27 |
| PROCTER & GAMBLE COMPANY | Chief Tech/Sci/R&D Officer | 2005-06-29 |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Director/Board Member | - |
Training of Adam Houghton
| Xavier University | Masters Business Admin |
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
| Biogen Corp. Ltd. | |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
- Stock Market
- Insiders
- Adam Houghton
